Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-17 of 17 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

    Jacksonville, FL, Rochester, MN

  2. A Study to Evaluate Circulating Cell Free Tumor DNA as a Biomarker in Sarcoma

    Rochester, MN

  3. Localized Leiomyosarcoma Biomarker Protocol

    Rochester, MN

  4. Metastatic Leiomyosarcoma Biomarker Protocol

    Rochester, MN, Jacksonville, FL

  5. Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young

    Rochester, MN

  6. Collection of Primary Retroperitoneal Sarcoma Data, Radiological, and Pathological Material for the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

    Jacksonville, FL

  7. Retrospective Review of Radiological Findings of Uterine Leiomyosarcoma in Comparison with Those of Atypical Leiomyoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer